{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-004798","form_type":"8-K","ticker":"MASS","cik":"0001555279","company_name":"908 Devices Inc.","filed_at":"2026-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.417138+00:00","generated_at":"2026-05-16T09:32:31.727651+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"908 Devices Q4 revenue $17.2M (+20% YoY); FY2025 ~$56M (+17%), positive Adj. EBITDA in Q4","bullets":["Q4 2025 revenue ~$17.2M versus $14.3M in Q4 2024, growth of ~20%.","FY2025 revenue ~$56.0M, up ~17% from $47.7M in FY2024, at high end of guidance.","Achieved positive Adjusted EBITDA in the fourth quarter, meeting a key goal.","Strength from U.S. state/local channel, ramping VipIR international sales, and federal/defense customers.","CEO cites macro tailwinds: increased fentanyl/opioid crisis funding and rising global defense budgets."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-004798","json":"https://secwatch.observer/filing/0001104659-26-004798.json","markdown":"https://secwatch.observer/filing/0001104659-26-004798.md","text":"https://secwatch.observer/filing/0001104659-26-004798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555279/000110465926004798/0001104659-26-004798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555279/000110465926004798/mass-20260120x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:32:31.727651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}